2m 2m 2m 2m 2m 2m 2m
INHIBIKASE THRP (IKT)
NASDAQ
$2.33-$0.010 (-0.43%)
Price as of Sep 11, 2026 7:30 PM EDT- $326.5MMarket Cap
- 50.00%1-Year Change
- BiotechnologyIndustry
INHIBIKASE THRP (IKT)
$2.33-$0.010 (-0.43%)
Earnings Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 43.71% | ||
12-Month Momentum | 42.86% | ||
3-Month Risk Adjusted Momentum | 200.23% | ||
12-Month Risk Adjusted Momentum | 69.46% |
True Yield
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.03% |
Financial Health Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -4 |